Month: September 2025

Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients

First patient in South Korea dosedMIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the...

Trially AI Seed Round Secures $4.7M and Launches “Margo” to Solve Clinical Trial Recruitment Bottleneck

AI-first platform transforms recruitment delays into instant enrollments by matching, engaging and enrolling patients in clinical trials.KANSAS CITY, Mo.--(BUSINESS WIRE)--Trially®,...

Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

- Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives...

Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives as...

error: Content is protected !!